Articles

Find an Article

Filter articles

Showing 3481 to 3490 of 3693 results

Will the future of gene patents be "markedly different" after Myriad?

01-12-2010BiotechnologyLee Crews and Vicki Norton

A US district court decision threatens the future of so-called ‘gene patents’ in the US. Lee Crews and Vicki Norton look at the current position and assess the possible futures for the case.

Counterfeit medicines - the quintessential borderless crime

01-12-2010

The global spread of counterfeit pharmaceuticals presents a formidable challenge to public health. WIPR asked lawyers from Baker & McKenzie offices around the world about this growing menace and what IP rights owners can do.

Towards an EU patent

EPO, EU01-12-2010

People have been talking about a single Europe-wide patent for more than 60 years, although political concerns always seem to get in the way. WIPR talks to four key stakeholders about what the future holds.

France catches up

France01-12-2010

The European Patent Convention 2000 introduced new provisions enabling a patentee to limit the claims of its patent, even though the patent has been definitively granted. Now similar provisions have been introduced into French law.

Taking the next step in brand and patent security

01-12-2010Dean Hart

While pharmaceutical companies suffer greatly from the counterfeit drugs trade, it is important to remember that, ultimately, it is patients who suffer the most. Dean Hart explains.

Prepare for a clash of IP cultures

01-12-2010Gary Johnson

Consumer-grade medical devices are growing in popularity across the developed world in response to lifestyle-related health problems and an increased demand for personal influence over medical decisions.

Harnessing IP: strategies for SMEs

India01-12-2010Kajigailiu Gaiduwan Kamei

With the continuous shift towards a knowledge-based and innovation-driven economy, IP is a key consideration in day-to-day business decisions. But SMEs are not always as well versed as they should be, says Kajigailiu Gaiduwan Kamei.

Unwelcome diversions

01-12-2010Ross Bulla

Diversion is the trade of a genuinely branded product through channels of distribution that are unauthorised or unintended, and not supported by the original manufacturer or authorised distributors. Ross Bulla looks at how to deal with it.

.Brand of opportunities

01-12-2010Ben Anderson

The new gTLD programme is borne out of a lengthy policy development process. It facilitates greater innovation and choice within the Internet’s addressing system and allows the opportunity to create new digital identities.

The doubtful future of public private partnerships

Brazil01-12-2010Otto Licks and Felipe Mesquita

The relative stability of the Brazilian economy and the large amount of public funds earmarked for the national health budget have sparked the interest of the pharmaceutical industry.

Showing 3481 to 3490 of 3693 results

Directory

Service Providers

Mayora IP

Law Firms

Patpol – European and Polish Patent and Trademark Attorneys
Poland

HSM IP
Caribbean, EU, Central America, Latin America, South America

Kyosei International Patent Office
Japan

CNV ADVOGADOS

Banwo & Ighodalo
Nigeria, Ghana, OAPI, ARIPO

Adams & Adams Attorneys

Johansson & Langlois
Chile

CCPIT Patent & Trademark Law Office
China

WIPR